Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [2]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-38039 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- SLC29A3 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- A recommended positive control is mouse bladder tissue lysate.
- Concentration
- 1 mg/mL
Submitted references A novel 3' untranslated region mutation in the SLC29A3 gene associated with pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus syndrome.
Riachi M, Bas F, Darendeliler F, Hussain K
Pediatric diabetes 2019 Jun;20(4):474-481
Pediatric diabetes 2019 Jun;20(4):474-481
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of SLC29A3 in mouse bladder tissue lysate using a SLC29A3 polyclonal antibody (Product # PA5-38039) at a dilution of 1 µg/mL.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western Blot analysis of SLC29A3 in mouse bladder tissue lysate with SLC29A3 Polyclonal Antibody (Product # PA5-38039) at (A) 1 and (B) 2 µg/mL.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence of SLC29A3 in rat colon muscle tissue with SLC29A3 Polyclonal Antibody (Product # PA5-38039) at 20 µg/mL.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry of SLC29A3 in rat colon tissue with SLC29A3 Polyclonal Antibody (Product # PA5-38039) at 5 µg/mL.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Protein expression studies showing a decrease in ENT3 levels in patients M and N compared to two controls. (A) Western blot showing almost undetectable levels of ENT3 in both patients M and N compared to the controls. (B and C )Densitometry results showing a reduction of ENT3 expression by 85.7% in the patients compared to the controls
